WDR70 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.093800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.470110E-02
Normal-vs-Stage2
2.197800E-01
Normal-vs-Stage3
2.009800E-01
Normal-vs-Stage4
2.323800E-01
Stage1-vs-Stage2
6.377400E-01
Stage1-vs-Stage3
7.744400E-01
Stage1-vs-Stage4
3.520800E-01
Stage2-vs-Stage3
6.317800E-01
Stage2-vs-Stage4
7.010200E-01
Stage3-vs-Stage4
4.880600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.832180E-01
Normal-vs-AfricanAmerican
3.518600E-01
Normal-vs-Asian
6.619400E-01
Caucasian-vs-AfricanAmerican
9.641000E-01
Caucasian-vs-Asian
1.877000E-01
AfricanAmerican-vs-Asian
5.469800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.520420E-01
Normal-vs-Female
2.898200E-01
Male-vs-Female
6.314400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.686200E-02
Normal-vs-Age(41-60Yrs)
3.768600E-01
Normal-vs-Age(61-80Yrs)
1.501820E-01
Normal-vs-Age(81-100Yrs)
1.528170E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.146200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.533190E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.202000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.616440E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.905800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.153600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.823800E-02
Normal-vs-Daily Drinker
2.711200E-01
Normal-vs-Weekly Drinker
9.555000E-01
Normal-vs-Occasional Drinker
1.975210E-01
Normal-vs-Social Drinker
1.218980E-01
Non Drinker-vs-Daily Drinker
2.848000E-01
Non Drinker-vs-Weekly Drinker
1.789750E-01
Non Drinker-vs-Occasional Drinker
1.280800E-01
Non Drinker-vs-Social Drinker
1.741180E-01
Daily Drinker-vs-Weekly Drinker
3.591000E-01
Daily Drinker-vs-Occasional Drinker
7.706600E-01
Daily Drinker-vs-Social Drinker
8.647600E-01
Weekly Drinker-vs-Occasional Drinker
4.200000E-01
Weekly Drinker-vs-Social Drinker
3.898200E-01
Occasional Drinker-vs-Social Drinker
8.905000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.859200E-01
Normal-vs-Grade 2
7.005000E-01
Normal-vs-Grade 3
7.201600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.794200E-01
Grade 1-vs-Grade 3
1.164450E-01
Grade 1-vs-Grade 4
6.859200E-01
Grade 2-vs-Grade 3
1.742770E-01
Grade 2-vs-Grade 4
7.005000E-01
Grade 3-vs-Grade 4
7.201600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.033800E-02
Normal-vs-NonDiabetic
2.783600E-01
Diabetic-vs-NonDiabetic
3.979000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.884600E-01
Normal-vs-NoPancreatitis
2.298600E-01
Pancreatitis-vs-NoPancreatitis
1.757210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.079560E-01
Normal-vs-N1
2.538000E-01
N0-vs-N1
8.388400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.985400E-01
Normal-vs-TP53-NonMutant
2.506600E-01
TP53-Mutant-vs-TP53-NonMutant
8.471800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
